Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 10
Submit an article Journal homepage
281
Views
20
CrossRef citations to date
0
Altmetric
Original article: Research

Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma

Maria WysockaDepartment of Dermatology, Philadelphia, PA, USACorrespondence[email protected]
,
Noor DawanyThe Wistar Institute, Philadelphia, PA, USA
,
Bernice BenoitDepartment of Dermatology, Philadelphia, PA, USA
,
Andrew V. KossenkovThe Wistar Institute, Philadelphia, PA, USA
,
Andrea B. TroxelCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA
,
Joel M. GelfandDepartment of Dermatology, Philadelphia, PA, USA
,
Michael kelly SellDepartment of Dermatology, Philadelphia, PA, USA
,
Louise C. ShoweThe Wistar Institute, Philadelphia, PA, USA
&
Alain H. RookDepartment of Dermatology, Philadelphia, PA, USA
 show all
Pages 1970-1979 | Received 04 Jan 2011, Accepted 12 Apr 2011, Published online: 23 Sep 2011

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Andreas Willerslev-Olsen, Ivan V Litvinov, Simon M Fredholm, David L Petersen, Nina A Sibbesen, Robert Gniadecki, Qian Zhang, Charlotte M Bonefeld, Mariusz A Wasik, Carsten Geisler, Youwen Zhou, Anders Woetmann, Denis Sasseville, Thorbjørn Krejsgaard & Niels Ødum. (2014) IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). Cell Cycle 13:8, pages 1306-1312.
Read now

Articles from other publishers (19)

Maria Leśniak, Justyna Lipniarska, Patrycja Majka, Weronika Kopyt, Monika Lejman & Joanna Zawitkowska. (2023) The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies. Vaccines 11:2, pages 277.
Crossref
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Q. Khan, Fareed Ahmad, Majid Alam, Joerg Buddenkotte, Aamir Ahmad, Martin Steinhoff & Shahab Uddin. (2022) Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways. Seminars in Cancer Biology 86, pages 382-399.
Crossref
Natalia Rendón‐Serna, Luis A. Correa‐Londoño, Margarita M. Velásquez‐Lopera & Maria Bermudez‐Muñoz. (2021) Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment. International Journal of Dermatology 60:12, pages 1462-1480.
Crossref
Jean-Baptiste Gorin, Jérémie Ménager, Yannick Guilloux, Jean-François Chatal, Joëlle Gaschet & Michel Chérel. 2018. Resistance to Ibritumomab in Lymphoma. Resistance to Ibritumomab in Lymphoma 119 137 .
Kelly C.G. Manfrere, Marina P. Torrealba, Denis R. Miyashiro, Nátalli Z. Pereira, Fabio S.Y. Yoshikawa, Luana de M. Oliveira, Jade Cury-Martins, Alberto J.S. Duarte, José A. Sanches & Maria N. Sato. (2017) Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome. Oncotarget 8:54, pages 92183-92194.
Crossref
A. M. El Tawdy, I. M. Amin, R. M. Abdel Hay, A. S. Hassan, Z. S. Gad & L. A. Rashed. (2017) Toll-like receptor (TLR)7 expression in mycosis fungoides and psoriasis: a case-control study. Clinical and Experimental Dermatology 42:2, pages 172-177.
Crossref
Sasha Stephen, Ellen J. Kim, Camille E. Introcaso, Stephen K. Richardson & Alain H. Rook. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology 715 740 .
Kelly C. G. Manfrere, Marina P. Torrealba, Denis R. Miyashiro, Luanda M. S. Oliveira, Gabriel C. de Carvalho, Josenilson F. Lima, Anna Claudia C. C. Branco, Nátalli Z. Pereira, Juliana Pereira, José A. SanchesJrJr & Maria N. Sato. (2016) Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome. Oncotarget 7:46, pages 74592-74601.
Crossref
Gregory N. Dietsch, Hailing Lu, Yi Yang, Chihiro Morishima, Laura Q. Chow, Mary L. Disis & Robert M. Hershberg. (2016) Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity. PLOS ONE 11:2, pages e0148764.
Crossref
Simone M. Goldinger, Emmanuella Guenova, Kazuyasu Fujii & Mirjana Urosevic-Maiwald. 2016. Immunology of the Skin. Immunology of the Skin 463 475 .
Auris O. Huen & Alain H. Rook. (2014) Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma. Current Opinion in Oncology 26:2, pages 237-244.
Crossref
Sara Harsini, Maani Beigy, Mahsa Akhavan-Sabbagh & Nima Rezaei. (2014) Toll-like receptors in lymphoid malignancies: Double-edged sword. Critical Reviews in Oncology/Hematology 89:2, pages 262-283.
Crossref
Reinhard DummerSima Rozati, Emmanuella Guenova & Antonio Cozzio. (2013) Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas. Future Oncology 9:8, pages 1061-1064.
Crossref
Maarten BuitendijkSusan K. EszterhasAlexandra L. Howell. (2013) Gardiquimod: A Toll-Like Receptor-7 Agonist That Inhibits HIV Type 1 Infection of Human Macrophages and Activated T Cells. AIDS Research and Human Retroviruses 29:6, pages 907-918.
Crossref
Pamela D. Martin & David J. Argyle. 2013. Advances in Veterinary Dermatology. Advances in Veterinary Dermatology 187 196 .
Pamela D. Martin & David J. Argyle. (2013) Advances in the management of skin cancer. Veterinary Dermatology 24:1, pages 173-e38.
Crossref
Michael J. Kelly‐Sell, Youn H. Kim, Suzanne Straus, Bernice Benoit, Cameron Harrison, Katherine Sutherland, Randall Armstrong, Wen‐Kai Weng, Louise C. Showe, Maria Wysocka & Alain H. Rook. (2012) The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T‐cell lymphoma patients. American Journal of Hematology 87:4, pages 354-360.
Crossref
A. Shah & A. Safaya. (2012) Granulomatous slack skin disease: a review, in comparison with mycosis fungoides. Journal of the European Academy of Dermatology and Venereology, pages no-no.
Crossref
Alain H. Rook. (2012) The beauty of TLR agonists for CTCL. Blood 119:2, pages 321-322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.